Quisinostat (JNJ-26481585) 2HCl

Quisinostat (JNJ-26481585) 2HCl is a novel second-generation HDAC inhibitor with highest potency for HDAC1 with IC50 of 0.11 nM in a cell-free assay, modest potent to HDACs 2, 4, 10, and 11; greater than 30-fold selectivity against HDACs 3, 5, 8, and 9 and lowest potency to HDACs 6 and 7. Phase 2.
Supplier Selleck Chemicals
Product # S1096
Sku # S1096-5mg
Pricing 5mg, $210.00
Feedback